PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Perit Dial Int 27(Supplement_2): 158-163
2007
© 2007 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, P. K.
Right arrow Articles by Cheng, Y. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Li, P. K.
Right arrow Articles by Cheng, Y. L.

Part 4: Technical Advances in PD

THERAPEUTIC OPTIONS FOR PRESERVATION OF RESIDUAL RENAL FUNCTION IN PATIENTS ON PERITONEAL DIALYSIS

Philip KamTao Li1 and Yuk Lun Cheng2

Department of Medicine and Therapeutics,1 Prince of Wales Hospital, Chinese University of Hong Kong, and Department of Medicine,2 Alice Ho Miu Ling Nethersole Hospital, Hong Kong SAR, PR China

Correspondence to: P.K.T. Li, Division of Nephrology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, PR China. philipli{at}cuhk.edu.hk

Dialysis is not the ideal renal replacement therapy because it does not fully restore all kidney functions. Increasing evidence suggests that preservation of residual renal function is associated with a survival benefit, a decrease in morbidity, better nutrition, a lower level of inflammatory markers, an improved quality of life, and cost savings by obviating the need for more peritoneal dialysis exchanges and possibly by reducing the requirement for antihypertensive agents, phosphate binders, and erythropoietin. In the present article, we review the impact of residual renal function on patient outcomes and the renoprotective strategies available in patients on peritoneal dialysis.

KEY WORDS: Residual renal function; renoprotective strategy.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
J. T. Park, D. K. Kim, T. I. Chang, H. W. Kim, J. H. Chang, S. Y. Park, E. Kim, S.-W. Kang, D.-S. Han, and T.-H. Yoo
Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients
Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3520 - 3525.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
C.-T. Liao, Y.-M. Chen, C.-C. Shiao, F.-C. Hu, J.-W. Huang, T.-W. Kao, H.-F. Chuang, K.-Y. Hung, K.-D. Wu, and T.-J. Tsai
Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis
Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2909 - 2914.
[Abstract] [Full Text] [PDF]

Home page
 pdiHome page
I. Sundl, J. M. Roob, A. Meinitzer, B. Tiran, G. Khoschsorur, B. Haditsch, H. Holzer, and B. M. Winklhofer-Roob
ANTIOXIDANT STATUS OF PATIENTS ON PERITONEAL DIALYSIS: ASSOCIATIONS WITH INFLAMMATION AND GLYCOXIDATIVE STRESS
Perit. Dial. Int., January 1, 2009; 29(1): 89 - 101.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2007 by Multimed Inc.